I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 19 studies | 50% ± 15% | |
| glutamatergic neuron | 11 studies | 47% ± 25% | |
| oligodendrocyte | 11 studies | 24% ± 10% | |
| astrocyte | 10 studies | 34% ± 17% | |
| retinal cone cell | 9 studies | 59% ± 21% | |
| oligodendrocyte precursor cell | 9 studies | 30% ± 13% | |
| GABAergic neuron | 8 studies | 41% ± 22% | |
| neuron | 6 studies | 30% ± 8% | |
| interneuron | 6 studies | 46% ± 23% | |
| amacrine cell | 6 studies | 32% ± 13% | |
| endothelial cell | 5 studies | 32% ± 14% | |
| retinal ganglion cell | 5 studies | 39% ± 19% | |
| epithelial cell | 5 studies | 22% ± 1% | |
| retinal bipolar neuron | 4 studies | 24% ± 8% | |
| retina horizontal cell | 4 studies | 25% ± 9% | |
| type B pancreatic cell | 3 studies | 40% ± 18% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 3% | |
| GABAergic interneuron | 3 studies | 29% ± 4% | |
| granule cell | 3 studies | 29% ± 6% | |
| lymphocyte | 3 studies | 21% ± 4% | |
| rod bipolar cell | 3 studies | 26% ± 5% | |
| ependymal cell | 3 studies | 51% ± 16% | |
| gamma-delta T cell | 3 studies | 20% ± 2% | |
| adipocyte | 3 studies | 16% ± 1% |
